Influenza, Human  >>  tofacitinib  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
tofacitinib / Generic mfg.
NCT01359150: A Study To Assess the Immune Response Following Administration Of Influenza and Pneumococcal Vaccines To Subjects With Rheumatoid Arthritis Receiving CP-690,550 Or Placebo

Checkmark EULAR 2013: Rheumatoid arthritis
May 2013 - May 2013: EULAR 2013: Rheumatoid arthritis
Completed
2
223
US, Europe
CP-690,550, placebo
Pfizer
Rheumatoid Arthritis
02/12
02/12

Download Options